KELSEY RAMSEY: Open Payments
NPI 1922501477 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 20 payments from 10 companies in 2025. Trend: 2023 $309 · 2024 $282 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| SHIELD THERAPEUTICS INC | 4 | $234 |
| Daiichi Sankyo Inc. | 4 | $76 |
| Exeltis, USA Inc. | 3 | $66 |
| Biogen, Inc. | 2 | $50 |
| Organon LLC | 2 | $29 |
| Astellas Pharma US Inc | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| PFIZER INC. | 1 | $20 |
| MILLICENT US INC | 1 | $19 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $15 |
Products named: ACCRUFER, INJECTAFER, SLYND, ZURZUVAE, NEXPLANON, Veozah, Lynkuet, ABRYSVO.
Industry payments across GA — which companies pay providers there.
